Back to BlackRock, Inc. BlackRock, Inc.

ATNMATNM
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ACTINIUM PHARMACEUTICALS INC

BlackRock, Inc. holds 395,896 shares of ATNM (ACTINIUM PHARMACEUTICALS INC), worth $387,978 as of 2026-Q2. The position was increased (+6.7% shares).

Current Value

$387,978

Current Shares

395,896

Total Value Change

-$2.1M

Total Shares Change

-1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
395,896
+6.7%
$387,9780.0%$0.98
17
2026-Q1
Increased
371,210
+1.2%
$369,4660.0%$1.11
16
2025-Q4
Increased
366,931
+0.9%
$499,0260.0%$1.41
17
2025-Q3
Decreased
363,486
-22.3%
$581,5770.0%$1.62
0
2025-Q2
Decreased
467,673
-76.0%
$654,7430.0%$1.42
0
2025-Q1
Decreased
1.9M
-1.3%
$3.1M0.0%$1.81
0
2024-Q4
New
2M
-
$2.5M0.0%$1.17
36

Other major holders of ATNM: BlackRock Finance, Inc., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used